Literature DB >> 25436294

Postoperative surveillance and prognostic factors in patients with esophageal cancer.

Chikara Kunisaki, Hirochika Makino, Jun Kimura, Mitsuyoshi Ota, Ryo Takagawa, Takashi Kosaka, Hidetaka A Ono, Hirotoshi Akiyama, Itaru Endo.   

Abstract

BACKGROUND/AIMS: Here we investigated postoperative prognostic factors and surveillance in patients with esophageal cancer. METHODOLOGY Prognostic factors were evaluated at several different postoperative stages in 257 patients with curative (R0) esophagectomy. Cause of death and pattern of tumor recurrence were also analyzed.
RESULTS: There was a significant difference in the distribution of cause of death according to the time after surgery (p<0.001). The pattern of recurrence also differed according to the time after surgery, although this was not statistically significant. A Cox proportional regression hazard model for disease-specific survival revealed that Tumor-Node-Metastasis (TNM) stage was an independent prognostic factor only from the time of initial surgery until the third postoperative year, and no postoperative prognostic factors were detected after the fourth and fifth years. There were significant differences in disease-specific survival among pathological TNM stages between the time of initial surgery and postoperative year five, but not between stages I and II at postoperative years two, three, or four. There were no significant differences between the stages at postoperative year five. Relapse-free survival differed between stages II and III at postoperative year five, although the other results were similar to those for disease-specific survival.
CONCLUSIONS: Prognostic factors for esophageal cancer alter during the postoperative period. Although the pathological stage at the time of initial surgery has less prognostic power after 3 years, it remains important to monitor treatments for esophageal cancer continuously, as well as concomitant diseases and other malignancies.

Entities:  

Mesh:

Year:  2014        PMID: 25436294

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  3 in total

1.  Correlation between NAD(P)H: quinone oxidoreductase 1 C609T polymorphism and increased risk of esophageal cancer: evidence from a meta-analysis.

Authors:  Jingfang Diao; Jie Bao; Jianxin Peng; Jiaqiang Mo; Qing Ye; Junming He
Journal:  Ther Adv Med Oncol       Date:  2016-09-18       Impact factor: 8.168

2.  Serum thymidine kinase 1 levels correlate with clinical characteristics of esophageal squamous cell carcinoma.

Authors:  Yong Ji; Xiao-Bo Wu; Jing-Yu Chen; Bin Hu; Qian-Kun Zhu; Xing-Feng Zhu; Min-Feng Zheng
Journal:  Int J Clin Exp Med       Date:  2015-08-15

3.  What are the independent prognostic factors in patients undergoing esophagectomy for esophageal cancer?

Authors:  Sermin Alcan; Makbule Ergin; Hakan Keskin; Abdullah Erdoğan
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2022-01-28       Impact factor: 0.332

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.